A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
about
Met in urological cancersControversies and challenges in research on urogenital schistosomiasis-associated bladder cancerFibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancerA systematic experimental evaluation of microRNA markers of human bladder cancer.The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability.Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway.Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer.FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer.
P2860
Q26864988-138EA48F-7204-45DB-BD19-7CEAC00C74E0Q27008499-73EA3F6B-6F0C-4040-82DC-8FB16A6FC7B2Q37001322-11E1CAC3-E2C4-4D84-9160-E5D4CE3E600EQ37309960-706B32C2-E9C6-4995-970C-CE5D7C5AD44EQ38930235-6F310A2D-BA03-4EBB-B2CB-71BD20CBF601Q51567761-5C434A1C-B6F0-4B8A-BC6E-1899E04A202FQ52816722-DDE0DD24-7935-48FE-8F3D-396023897D08Q54188080-D4ABC6B0-22B7-4F06-B74E-C0F60412C945Q54348729-4E2E0595-3E17-4C09-BC2E-95C83A257A5E
P2860
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@ast
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@en
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@nl
type
label
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@ast
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@en
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@nl
prefLabel
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@ast
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@en
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.
@nl
P2093
P2860
P50
P1433
P1476
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer
@en
P2093
Agnès Laplanche
Amel El Gaaied
Ashraf Bakkar
Audrey Renou
Aurélie Herault
Bernard Asselain
Claude-Clément Abbou
Dimitri Vordos
Hany Soliman
Hugues de The
P2860
P304
P356
10.1371/JOURNAL.PONE.0048993
P407
P577
2012-12-13T00:00:00Z